Avidity Biosciences, Inc.
RNA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$322 | -$212 | -$174 | -$118 |
| Dep. & Amort. | $3 | $2 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $51 | $38 | $27 | $17 |
| Change in WC | -$15 | $61 | $10 | $5 |
| Other Non-Cash | -$18 | -$8 | -$1 | $0 |
| Operating Cash Flow | -$301 | -$119 | -$136 | -$95 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7 | -$4 | -$3 | -$4 |
| Net Acquisitions | $0 | $0 | $187 | $83 |
| Inv. Purchases | -$1,434 | -$461 | -$356 | -$85 |
| Inv. Sales/Matur. | $586 | $335 | $169 | $7 |
| Other Inv. Act. | $0 | $0 | -$187 | -$83 |
| Investing Cash Flow | -$854 | -$130 | -$190 | -$83 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1,001 | $61 | $345 | $175 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $192 | $33 | $1 | $2 |
| Financing Cash Flow | $1,192 | $94 | $346 | $176 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $37 | -$155 | $20 | -$1 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $185 | $341 | $321 | $322 |
| End Cash | $223 | $185 | $341 | $321 |
| Free Cash Flow | -$308 | -$123 | -$139 | -$99 |